- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on c-MET Positive Gastric Cancer in United States
Total 1230 results
-
Royal Marsden NHS Foundation TrustTerminatedOesophago-gastric CancerUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedStomach Cancer | Esophageal CancerUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced Gastric CancerSpain, Belgium, France, Italy, United States, Korea, Republic of, Japan, Germany
-
Harry H YoonMayo Clinic; Merck Sharp & Dohme LLCRecruitingAdenocarcinoma | Gastric Cancer | GastroEsophageal CancerUnited States
-
Seagen Inc.CompletedHER2 Positive Metastatic Breast CancersUnited States
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Adenocarcinoma | Gastro-esophageal Junction CancerKorea, Republic of, United States, Japan, Taiwan, China, United Kingdom, Netherlands
-
Finch Research and Development LLC.Medpace, Inc.CompletedClostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal TransplantUnited States, Canada
-
National Cancer Institute (NCI)RecruitingGastric Cancer | Pancreatic Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal CancerUnited States
-
National Cancer Institute (NCI)RecruitingGastric Cancer | Pancreatic Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal CancerUnited States
-
Lumicell, Inc.National Cancer Institute (NCI)RecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal CancerUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Dana-Farber Cancer InstituteRecruitingGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage II Gastric Cancer | Stage III Gastric Cancer | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Stomach | Adenocarcinoma of the Esophagus | Stage III Esophageal Cancer | Stage II Esophageal CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ)Enrolling by invitationClostridium Difficile Infection | Clostridium Difficile | C Difficile ColitisUnited States
-
Weill Medical College of Cornell UniversityDamon Runyon Cancer Research FoundationActive, not recruitingGastric Cancer | Pancreatic Cancer | Small Bowel Cancer | Rectal Cancer | Colon Cancer | Hepatic CancerUnited States
-
Eisai Inc.Quintiles, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Previously Untreated Gastric CancerUnited States, Russian Federation, United Kingdom, Ukraine
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal ComplicationsUnited States
-
M.D. Anderson Cancer CenterNot yet recruiting
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer Network; Puma Biotechnology, Inc.RecruitingNeratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal CancerGastric Cancer | GastroEsophageal CancerUnited States
-
National Cancer Institute (NCI)CompletedStomach Cancer | Gastric CancerUnited States
-
Dana-Farber Cancer InstituteCompletedGastric Cancer | Esophageal CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedGastric Cancer | Esophageal CancerUnited States
-
NYU Langone HealthFood and Drug Administration (FDA)CompletedStomach Cancer | Gastric CancerUnited States
-
NYU Langone HealthBristol-Myers Squibb; Eli Lilly and CompanyCompletedStomach Cancer | Gastric CancerUnited States
-
ViomeIcahn School of Medicine at Mount SinaiRecruitingGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Gastrointestinal Cancer | Liver Cancer | Biliary CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterTerminatedGastric Cancer | Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Junction Cancer | Gastric Tumor | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal Cancer | Esophageal Tumor | Esophagogastric Tumors | Gastroesophageal Junction TumorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma...United States
-
NYU Langone HealthCompletedGastric Cancer | GastroEsophageal CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedGastric Cancer | Gastroesophageal Cancer | Metastatic Esophageal CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
Mayo ClinicOlympusCompletedGastrointestinal Neoplasms | Gastric CancerUnited States
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; SCRI Development Innovations... and other collaboratorsCompletedStomach Cancer | Gastric Cancer | Esophageal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
SOFIERecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal CancersUnited States
-
Jonsson Comprehensive Cancer CenterTranslational Research in OncologyCompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Oral Complications | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States
-
Stanford UniversityUnited States Department of DefenseRecruitingBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited States
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Shadia Jalal, MDGlaxoSmithKline; Indiana University School of MedicineTerminatedAdenocarcinoma | Gastric Cancer | Esophageal CancerUnited States
-
Chimeric TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Neuroendocrine TumorsUnited States
-
University of Southern CaliforniaCompletedAdenocarcinoma | Gastric CancerUnited States
-
Dana-Farber Cancer InstituteCompletedGastro Intestinal CancerUnited States